<DOC>
	<DOCNO>NCT01254552</DOCNO>
	<brief_summary>This study aim answer clinical question prevalence myocardial scar asymptomatic patient type 2 Diabetes Mellitus special focus diagnostic efficacy Xenetix® 350-enhanced 64-rows MDCT visualisation coronary arterial tree secondarily assessment myocardial viability use Dotarem® enhanced-cardioMR gold standard examination .</brief_summary>
	<brief_title>Assessment With CCTA MRI Asymptomatic Patients With Type 2 Diabetes Detection Unrecognized Myocardial Scar Subclinical Coronary Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>Patient onset type 2 diabetes occur age 30 year old Patient age 50 75 year enrolment time Patient least two identified cardiac risk factor undergo CMR CCTA examination evaluate his/her coronary cardiac status Patient angina pectoris chest discomfort Patient stress test invasive coronary angiography within prior 3 year Patient history myocardial infarction , overt non compensate heart failure , coronary revascularization Patient hemodynamic instability . Patient contraindication intolerance BetaBlocker administration</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>